ClinicalTrials.Veeva

Menu

Rehabilitation of Facial Emotion Recognition in Alzheimer's Disease

A

Association de Recherche Bibliographique pour les Neurosciences

Status

Completed

Conditions

Alzheimer's Dementia (AD)
Family Caregivers

Treatments

Other: AD-Cognitive Stimulation
Other: AD-TAR

Study type

Observational

Funder types

Other

Identifiers

NCT05267028
EYE-TAR(AD+)

Details and patient eligibility

About

EYE-TAR(AD+) is an observational study based on the same design as the princeps EYE-TAR(MA) study, but with a larger number of patients and including an additional evaluation of Facial emotion recognition (based on a more ecological material), in order to reinforce conclusions of the study EYE-TAR(MA) https://doi.org/10.1016/j.npg.2020.08.003.

The main objective is to confirm that facial emotion recognition can be improved in AD using the "Training of Affect Recognition program" (TAR).

The Secondary Objectives are to:

Evaluate the impact of the "Training of Affect Recognition program" (TAR) on oculomotor behavior in a situation of social cognition, on behavioral disorders and on caregiver burden.

Confirm that improvement in facial emotion recognition is related to modification of observation strategies.

Confirm the link between improved recognition of facial emotions, reduced behavioral disorders and caregiver burden.

Enrollment

16 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Male or Female.
  • AD diagnosed according to l'IWG-2 (Dubois & al. 2014) criteria,
  • Mini-Mental State (MMS-E) ≥15
  • Subject accompanied by a family caregiver and whose participation in a cognitive stimulation workshop was recommended in Memory Centre of the RAINIER Centre (Princesses Grace Hospital - Monaco)
  • Written informed consent signed by patient and family caregiver.

Exclusion criteria

  • General anaesthesia within 3 months.
  • History of psychiatric and/or neurological disorder (other than the diagnosed neurodegenerative pathology);
  • History of alcoholism or drug addiction
  • Ophthalmological or neurological problems preventing a video-oculography examination.
  • Oculomotor disorders such as "fixation disorders" or "ocular tracking disorders".
  • Cognitive disorders of the neurovisual type (visual agnosia, prosopagnosia, visuo-spatial disorder or visuo-perceptual disorder) or aphasia.

Trial design

16 participants in 2 patient groups

AD-TAR
Description:
AD subjects who take part to Facial Emotion Recognition rehabilitation (TAR)
Treatment:
Other: AD-TAR
AD-Cognitive Stimulation
Description:
AD subjects who take part to cognitive stimulation session (12 sessions during 4 weeks)
Treatment:
Other: AD-Cognitive Stimulation

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems